Patient's Perspectives of Experimental HCV-Positive to HCV-Negative Renal Transplantation: Report from a Single Site.

Conclusions: Recipients of experimental HCV D+/R- transplants generally seemed to recognize the risks and benefits of these novel transplants and did not regret participating. Such salutary reported experiences are important in assessing the appropriateness of further research into the feasibility of HCV D+/R- transplants. PMID: 31618112 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31618112?dopt=Abstract

Source: AJOB Primary Research - October 17, 2019 Category: Medical Ethics Tags: AJOB Empir Bioeth Source Type: research